KIF2A report

Query

Invalid input gene. Please select from the suggestions.

I. Expression across cell types

Cell ontologyData table

Name	Number of supported studies	Average coverage
natural killer cell	26 studies	28% ± 10%	Explore
CD4-positive, alpha-beta T cell	26 studies	28% ± 9%	Explore
regulatory T cell	25 studies	29% ± 11%	Explore
CD8-positive, alpha-beta T cell	25 studies	29% ± 10%	Explore
T cell	19 studies	26% ± 8%	Explore
B cell	16 studies	21% ± 4%	Explore
mucosal invariant T cell	15 studies	32% ± 11%	Explore
ciliated cell	15 studies	30% ± 9%	Explore
naive thymus-derived CD4-positive, alpha-beta T cell	15 studies	32% ± 8%	Explore
naive thymus-derived CD8-positive, alpha-beta T cell	14 studies	34% ± 11%	Explore
CD16-positive, CD56-dim natural killer cell, human	14 studies	27% ± 6%	Explore
oligodendrocyte	14 studies	39% ± 16%	Explore
oligodendrocyte precursor cell	14 studies	39% ± 20%	Explore
CD16-negative, CD56-bright natural killer cell, human	13 studies	28% ± 8%	Explore
mature NK T cell	13 studies	31% ± 13%	Explore
endothelial cell	13 studies	27% ± 12%	Explore
dendritic cell	13 studies	38% ± 17%	Explore
CD8-positive, alpha-beta memory T cell	12 studies	30% ± 9%	Explore
gamma-delta T cell	12 studies	35% ± 11%	Explore
platelet	11 studies	54% ± 18%	Explore
GABAergic neuron	11 studies	36% ± 17%	Explore
effector memory CD8-positive, alpha-beta T cell	11 studies	32% ± 10%	Explore
astrocyte	11 studies	33% ± 13%	Explore
CD4-positive, alpha-beta memory T cell	10 studies	32% ± 8%	Explore
naive B cell	10 studies	21% ± 4%	Explore
glutamatergic neuron	9 studies	40% ± 22%	Explore
microglial cell	9 studies	28% ± 10%	Explore
neuron	8 studies	36% ± 16%	Explore
memory B cell	8 studies	20% ± 4%	Explore
basal cell	7 studies	21% ± 10%	Explore
retinal cone cell	7 studies	68% ± 9%	Explore
retinal rod cell	7 studies	33% ± 5%	Explore
plasmacytoid dendritic cell	7 studies	24% ± 5%	Explore
effector CD8-positive, alpha-beta T cell	6 studies	36% ± 12%	Explore
interneuron	6 studies	47% ± 20%	Explore
T follicular helper cell	6 studies	24% ± 9%	Explore
effector memory CD4-positive, alpha-beta T cell	6 studies	34% ± 7%	Explore
fibroblast	6 studies	18% ± 2%	Explore
hematopoietic stem cell	6 studies	36% ± 22%	Explore
effector CD4-positive, alpha-beta T cell	5 studies	35% ± 10%	Explore
leukocyte	5 studies	28% ± 7%	Explore
macrophage	5 studies	25% ± 7%	Explore
retinal ganglion cell	5 studies	25% ± 10%	Explore
amacrine cell	5 studies	27% ± 7%	Explore
retina horizontal cell	5 studies	24% ± 4%	Explore
effector memory CD8-positive, alpha-beta T cell, terminally differentiated	5 studies	32% ± 7%	Explore
central memory CD8-positive, alpha-beta T cell	4 studies	37% ± 14%	Explore
plasmablast	4 studies	38% ± 14%	Explore
epithelial cell	4 studies	34% ± 16%	Explore
conventional dendritic cell	4 studies	26% ± 10%	Explore
exhausted T cell	4 studies	27% ± 7%	Explore
lymphocyte	4 studies	29% ± 8%	Explore
megakaryocyte	4 studies	62% ± 22%	Explore
precursor B cell	4 studies	27% ± 6%	Explore
endothelial cell of lymphatic vessel	4 studies	22% ± 4%	Explore
abnormal cell	4 studies	26% ± 9%	Explore
megakaryocyte-erythroid progenitor cell	4 studies	43% ± 20%	Explore
double negative thymocyte	4 studies	42% ± 4%	Explore
CD4-positive helper T cell	3 studies	22% ± 3%	Explore
hematopoietic precursor cell	3 studies	34% ± 13%	Explore
GABAergic interneuron	3 studies	28% ± 5%	Explore
granule cell	3 studies	28% ± 4%	Explore
plasma cell	3 studies	25% ± 11%	Explore
immature B cell	3 studies	30% ± 6%	Explore
pro-B cell	3 studies	29% ± 4%	Explore
GABAergic amacrine cell	3 studies	24% ± 5%	Explore
OFF-bipolar cell	3 studies	18% ± 2%	Explore
ON-bipolar cell	3 studies	20% ± 3%	Explore
glycinergic amacrine cell	3 studies	21% ± 3%	Explore
rod bipolar cell	3 studies	21% ± 3%	Explore
innate lymphoid cell	3 studies	27% ± 7%	Explore
ependymal cell	3 studies	38% ± 16%	Explore
myofibroblast cell	3 studies	19% ± 2%	Explore
pericyte	3 studies	18% ± 2%	Explore
group 3 innate lymphoid cell	3 studies	30% ± 12%	Explore
T-helper 1 cell	3 studies	38% ± 17%	Explore
central memory CD4-positive, alpha-beta T cell	3 studies	41% ± 8%	Explore
erythrocyte	3 studies	25% ± 4%	Explore

II. Expression across tissues

sc-RNAseq dataData table

Name	Number of supported studies	Average coverage
brain	17 studies	34% ± 19%	Explore
peripheral blood	15 studies	27% ± 5%	Explore
eye	7 studies	26% ± 5%	Explore
lung	5 studies	23% ± 11%	Explore
bone marrow	4 studies	18% ± 3%	Explore
adipose	4 studies	17% ± 1%	Explore

Bulk RNAseq dataData table

Tissue	GTEx Coverage	GTEx Average TPM	GTEx Number of samples	TCGA Coverage	TCGA Average TPM	TCGA Number of samples
brain	100%	1642.41	2642 / 2642	100%	28.12	705 / 705
esophagus	100%	987.35	1444 / 1445	99%	11.60	182 / 183
breast	100%	1015.49	459 / 459	99%	11.88	1105 / 1118
lung	100%	1080.16	577 / 578	99%	10.39	1143 / 1155
uterus	100%	1031.65	170 / 170	99%	12.38	453 / 459
pancreas	100%	663.91	327 / 328	98%	8.05	174 / 178
ovary	100%	917.39	180 / 180	97%	8.64	418 / 430
intestine	100%	1014.57	966 / 966	97%	10.94	510 / 527
bladder	100%	1120.48	21 / 21	96%	9.45	484 / 504
stomach	97%	595.70	350 / 359	97%	10.88	278 / 286
thymus	100%	812.10	652 / 653	94%	8.17	569 / 605
adrenal gland	100%	745.69	258 / 258	91%	9.32	210 / 230
skin	100%	1273.07	1802 / 1809	90%	10.61	426 / 472
prostate	100%	908.58	245 / 245	89%	5.85	446 / 502
kidney	98%	602.62	87 / 89	85%	8.41	770 / 901
liver	69%	231.15	157 / 226	40%	2.22	162 / 406
lymph node	0%	0	0 / 0	100%	15.02	29 / 29
spleen	100%	1129.19	241 / 241	0%	0	0 / 0
tonsil	0%	0	0 / 0	100%	14.08	45 / 45
ureter	0%	0	0 / 0	100%	3.89	1 / 1
blood vessel	100%	934.44	1334 / 1335	0%	0	0 / 0
adipose	100%	1061.90	1203 / 1204	0%	0	0 / 0
peripheral blood	93%	1956.29	861 / 929	0%	0	0 / 0
muscle	86%	379.29	688 / 803	0%	0	0 / 0
heart	85%	382.25	735 / 861	0%	0	0 / 0
eye	0%	0	0 / 0	54%	3.45	43 / 80
abdomen	0%	0	0 / 0	0%	0	0 / 0
bone marrow	0%	0	0 / 0	0%	0	0 / 0
diaphragm	0%	0	0 / 0	0%	0	0 / 0
gingiva	0%	0	0 / 0	0%	0	0 / 0
nasal cavity	0%	0	0 / 0	0%	0	0 / 0
nasopharynx	0%	0	0 / 0	0%	0	0 / 0
nose	0%	0	0 / 0	0%	0	0 / 0
placenta	0%	0	0 / 0	0%	0	0 / 0
spinal column	0%	0	0 / 0	0%	0	0 / 0